Farther Finance Advisors’s Disc Medicine IRON Stock Holding History

Farther Finance Advisors’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.21K	Buy	49 +2	+4%	+$151	﹤0.01%	5214
2026 Q2	$3.44K	Buy	47 +3	+7%	+$206	﹤0.01%	4973
2026 Q1	$2.85K	Sell	44 -9	-17%	-$625	﹤0.01%	4756
2025 Q4	$4.21K	Buy	53 +46	+657%	+$3.89K	﹤0.01%	4395
2025 Q3	$463	Buy	+7	New	+$416	﹤0.01%	4560

Other funds holding IRON

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's IRON Position: Q3 2026 in Review

Farther Finance Advisors increased its Disc Medicine (IRON) stake by 4.3% in Q3 2026, buying an estimated $151 and bringing the position to 49 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #5214.

Farther Finance Advisors first reported a position in IRON in Q3 2025 and has held it in 5 quarters since. The position peaked at $4.21K in Q4 2025. 3 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

Farther Finance Advisors held 49 shares of Disc Medicine worth $3.21K as of Q3 2026.
Farther Finance Advisors bought 2 Disc Medicine shares in Q3 2026, an estimated $151.
Disc Medicine made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5214 holding.
Farther Finance Advisors first reported a position in Disc Medicine in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's Disc Medicine position peaked at $4.21K in Q4 2025.
3 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.